$7.50
-0.36-4.58%
At Close: -
$7.50
00.00%
After Hours: 5:37 PM EDT
15 minutes delayed
Comments
Loading...
Relay Therapeutics (RLAY) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestRelay Therapeutics (NASDAQ:RLAY) Stock Quotes, Forecast and News Summary
Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
| Open | $7.79 |
| Close | $7.50 |
| Volume / Avg. | 2.19M / 1.86M |
| Day Range | $7.32 - $7.86 |
| 52 Wk Range | 5.70 - 12.14 |
| Market Cap | $1.22B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 6.81% |
| Days to Cover | 12.61 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Relay Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discover...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Relay Therapeutics (RLAY) stock?
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Who are Relay Therapeutics (RLAY) competitors?
Other companies in Relay Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for Relay Therapeutics (RLAY) stock?
Relay Therapeutics has a consensus price target of $24.00.
What is the current price for Relay Therapeutics (RLAY)?
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $7.5 last updated September 20, 2024 at 5:37 PM EDT.
Does Relay Therapeutics (RLAY) pay a dividend?
There are no upcoming dividends for Relay Therapeutics.
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
Relay Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Relay Therapeutics (RLAY) going to split?
There is no upcoming split for Relay Therapeutics.
What sector and industry does Relay Therapeutics (RLAY) operate in?
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.